# Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients

> **NCT03046901** · NA · WITHDRAWN · sponsor: **Ochsner Health System**

## Conditions studied

- Primary Sclerosing Cholangitis
- Post- Orthotopic Liver Transplantation

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT03046901
- **Lead sponsor:** Ochsner Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12-07
- **Primary completion:** 2019-02-25
- **Final completion:** 2019-02-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** 0 subjects enrolled
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03046901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03046901, "Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03046901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*